Goodwin Biotechnology Inc.
(Life Science) companies, Biotechnology – Therapeutics
GBI is a fully integrated cGMP contract manufacturing organization (CMO) of monoclonal antibodies and recombinant proteins for pre-clinical and clinical trials, with over 16 years experience as an independant contract manufacturer; GBI has worked with companies of all sizes from small university spin-offs to major research institutes, government agencys and large established biopharmaceutical companies
No people are connected to this company
Products
Contract Research & Manufacturing | Goodwin Biotechnology Inc.
The company utilizes 3 different bioreactor technologies for manufacturing of Mabs (IgGs and IgMs) and recombinant proteins, offering fully compliant upstream cGMP manufacturing for your clinical trial material through Pase II; the bioreactors are capable of producing from 1 to over 5000 grams per lot: Batch or Fed-Batch Bioreactor; Perfused Hollow Fiber Bioreactor; Perfused FibraCell Disk Bioreactor.
More information about cGMP Bioreactor Service »
